AR110433A1 - Preparación oftalmológica - Google Patents

Preparación oftalmológica

Info

Publication number
AR110433A1
AR110433A1 ARP170103643A ARP170103643A AR110433A1 AR 110433 A1 AR110433 A1 AR 110433A1 AR P170103643 A ARP170103643 A AR P170103643A AR P170103643 A ARP170103643 A AR P170103643A AR 110433 A1 AR110433 A1 AR 110433A1
Authority
AR
Argentina
Prior art keywords
preparation
water soluble
fibrous carrier
ophthalmological
solid fibrous
Prior art date
Application number
ARP170103643A
Other languages
English (en)
Inventor
Vladimir Velebny
Adela Kotzianova
Katerina Knotkova
Original Assignee
Contipro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro As filed Critical Contipro As
Publication of AR110433A1 publication Critical patent/AR110433A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparación oftalmológica especialmente para el tratamiento y la prevención de enfermedades y de trastornos oftalmológicos. Esta preparación oftalmológica se encuentra en la forma de portador fibroso sólido que comprende fibras solubles en agua que contienen ácido hialurónico o su sal aceptable desde el punto de vista farmacéutico y/o su derivado y además contiene el polímero sintético soluble en agua y el principio activo, el portador fibroso sólido se disuelve al entrar en contacto con el ojo.
ARP170103643A 2016-12-23 2017-12-22 Preparación oftalmológica AR110433A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ2016-827A CZ2016827A3 (cs) 2016-12-23 2016-12-23 Oftalmologický prostředek

Publications (1)

Publication Number Publication Date
AR110433A1 true AR110433A1 (es) 2019-03-27

Family

ID=61070241

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170103643A AR110433A1 (es) 2016-12-23 2017-12-22 Preparación oftalmológica

Country Status (8)

Country Link
EP (1) EP3558264A1 (es)
KR (1) KR102511776B1 (es)
AR (1) AR110433A1 (es)
BR (1) BR112019012758A2 (es)
CZ (1) CZ2016827A3 (es)
JO (1) JOP20190137A1 (es)
MX (1) MX2019007485A (es)
WO (1) WO2018113805A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ202132A3 (cs) * 2021-01-26 2022-04-20 Contipro A.S. Prostředek pro hojení ran, způsob jeho výroby a použití

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
IT1296689B1 (it) * 1997-11-06 1999-07-14 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario
BR0311585A (pt) 2002-06-05 2005-05-10 Univ Florida Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricação
US20130136784A1 (en) 2007-10-11 2013-05-30 Robert J. Staab Methods for delivery of medication using dissolvable devices
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
JP5722217B2 (ja) * 2008-09-02 2015-05-20 アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｈｏｌｄｉｎｇｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用
US20110229551A1 (en) 2010-03-17 2011-09-22 Notus Laboratories, Inc. Drug delivery compositions and methods using nanofiber webs
WO2013171764A2 (en) 2012-04-30 2013-11-21 Rubicon Research Private Limited Ophthalmic formulations
CZ304303B6 (cs) * 2012-11-27 2014-02-19 Contipro Biotech S.R.O. Vlákna založená na hydrofobizovaném hyaluronanu, způsob jejich přípravy a použití, textilie na jejich bázi a použití
CZ304654B6 (cs) * 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ2013914A3 (cs) * 2013-11-21 2015-02-25 Contipro Biotech S.R.O. Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití
EP3108874A1 (en) * 2015-06-26 2016-12-28 TRB Chemedica AG Ophthalmologic pharmaceutical composition

Also Published As

Publication number Publication date
MX2019007485A (es) 2019-08-29
RU2019122292A (ru) 2021-01-26
KR20190099495A (ko) 2019-08-27
BR112019012758A2 (pt) 2019-11-26
CZ307158B6 (cs) 2018-02-07
EP3558264A1 (en) 2019-10-30
WO2018113805A1 (en) 2018-06-28
RU2019122292A3 (es) 2021-03-17
KR102511776B1 (ko) 2023-03-17
JOP20190137A1 (ar) 2019-06-11
CZ2016827A3 (cs) 2018-02-07

Similar Documents

Publication Publication Date Title
AR062046A1 (es) Soluciones oftalmicas
NZ597626A (en) Bicyclic compound and use thereof for medical purposes
BR112015029512A8 (pt) derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas
EP4324454A3 (en) Cross-linking agents and associated methods
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
EA201390353A1 (ru) Производное пиразолохинолина
MD3416631T2 (ro) Agenți terapeutici pentru bolile neurodegenerative
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
MX2021002321A (es) Nuevos metodos.
BR112012028437A2 (pt) solução oftálmica, e, método para tratar glaucoma ou hipertensão ocular
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
MY199237A (en) Methods of treating ocular conditions
TN2015000356A1 (en) Bicyclic compounds
MD3482754T2 (ro) Compoziții farmaceutice și utilizări direcționate spre tulburări de stocare lizozomale
MX355770B (es) Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico.
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
UY33153A (es) Formulación tópica oftálmica de péptidos
AR110433A1 (es) Preparación oftalmológica
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
MA56220A (fr) Formulations oculaires permettant l'administration de médicament et la protection du segment antérieur de l'oeil
WO2014117010A3 (en) Composition for ophthalmic administration
BR112019005224A2 (pt) forma de dosagem para alívio prolongado
WO2017152129A3 (en) Treatment of glaucoma and/or retinal diseases and formulations useful therefore
PH12015501538A1 (en) Topical ocular analgesic agents
EA200970562A1 (ru) Применение l-карнитина для получения лекарственного средства в форме глазных капель для лечения заболеваний роговицы